Iron chelation therapy for patients with sickle cell disease and iron overload.

Authors :: Inati A
Khoriaty E
Musallam KM
Taher AT
Source :: American journal of hematology [Am J Hematol] 2010 Oct; Vol. 85 (10), pp. 782-6.
Publication Year :: 2010

Subjects :: Administration, Oral
Anemia, Sickle Cell metabolism
Anemia, Sickle Cell therapy
Benzoates administration & dosage
Benzoates therapeutic use
Child
Deferasirox
Deferiprone
Deferoxamine administration & dosage
Deferoxamine adverse effects
Drug Monitoring
Humans
Infusion Pumps psychology
Infusions, Subcutaneous
Iron Chelating Agents administration & dosage
Iron Chelating Agents adverse effects
Iron Overload etiology
Male
Pain etiology
Patient Compliance
Pyridones administration & dosage
Pyridones therapeutic use
Sensation Disorders chemically induced
Social Isolation
Triazoles administration & dosage
Triazoles therapeutic use
Young Adult
Zinc deficiency
Anemia, Sickle Cell complications
Chelation Therapy psychology
Deferoxamine therapeutic use
Erythrocyte Transfusion adverse effects
Iron Chelating Agents therapeutic use
Iron Overload drug therapy

Full Text Access

Tools